[
    [
        {
            "time": "",
            "original_text": "干货！2021年生物医药行业龙头企业分析——天坛生物：重组后专攻血液制品、稳居行业龙头地位",
            "features": {
                "keywords": [
                    "生物医药",
                    "龙头企业",
                    "天坛生物",
                    "重组",
                    "血液制品",
                    "行业龙头"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "干货！2021年生物医药行业龙头企业分析——天坛生物：重组后专攻血液制品、稳居行业龙头地位",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 3,
                "Headline_Structure": 9,
                "Source_Recency": 3
            }
        }
    ]
]